✨ Free AI Report
Sanofi India Limited: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Sanofi India Limited
Research Preview

Sanofi India Limited: Business Overview, Financials & Competitive Analysis

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical...

Analyst-debate audio for Sanofi India Limited

AskCyborg analysts argue the bull and bear cases for Sanofi India Limited across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Sanofi India Limited OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Established pharma MNC with competitive insulin franchise and emerging cost efficiency gains, but facing valuation and profit...

Read the full analyst-debate transcript →
Industry Pharmaceuticals & Biotechnology
2 named competitors
4 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Sanofi India Limited Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Sanofi India Limited Overview

Pro stress-test →

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical Market.

Strategic Profile

Pro stress-test →

The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health. It also exports its products to approximately 24 countries.

Competitive Landscape

Pro stress-test →

Sanofi India competes in India's highly fragmented pharmaceutical market against major generic manufacturers and multinational peers. Its competitive advantage lies in the branded insulin franchise (31% market share), diverse therapeutic portfolio, and export capabilities across 24 countries. However, it faces pricing pressure and generic competition typical of the Indian market.

Industry Context

Sanofi India Limited operates in Pharmaceuticals & Biotechnology.

Key facts

Founded: 1956 · Headquarters: Mumbai, Maharashtra, India · Employees: 1,225 · Revenue: ₹20.13B (FY2024) · Market cap: ₹9,237 Cr (~$1.1B USD)

What the analysts stress-tested

The top findings that survived the multi-agent debate for Sanofi India Limited.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Sanofi India Limited has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Insulin & Diabetes CareCompeting insulin and diabetes care manufacturersCardiovascular & Chronic DiseaseGeneric and branded chronic disease therapies

Compare Sanofi India Limited with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Sanofi India Limited operates in Pharmaceuticals & Biotechnology. See how the rest of the sector scores on the Cyborg framework.

Browse Pharmaceuticals & Biotechnology research →
NEW · MCP server

Ask your AI assistant about Sanofi India Limited

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Sanofi India Limited and its top competitor on Cyborg Score”
“What did Sanofi India Limited do this quarter?”
“Is Sanofi India Limited a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Sanofi India Limited do?+
Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The Company is amongst the leading multinational companies (MNCs) in the Indian Pharmaceutical...
What is Sanofi India Limited's Cyborg Score?+
Sanofi India Limited has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Sanofi India Limited's main competitors?+
Named competitors include Insulin & Diabetes Care, Cardiovascular & Chronic Disease. The full competitive landscape is in the AskCyborg report.
How can I get the full Sanofi India Limited research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Sanofi India Limited research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Sanofi India Limited over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual